Access to Medicines and Health Products programme. Annual report 2022

Overview

Affordable access to quality-assured essential medicines, vaccines and health products at the national level requires that Member States have in place comprehensive pharmaceutical sector policies. These policies should cover medicines regulation, pharmacovigilance, procurement, supply, and distribution of medicines, selection and responsible use of medicines, as well as medicine pricing and reimbursement policies to address affordability for patients and health care systems. The 2022 annual report of the Access to Medicines and Health Products (‎AMP)‎ programme in the WHO Regional Office for Europe describes the work undertaken in collaboration with agencies and partners to support pharmaceutical sector strengthening in the region.